Molecular Targeted Therapeutics Market Research Reports

We offer market research, industry forecasts, and business analysis in the Molecular Targeted Therapeutics as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis.

Filter

Title Search

1 - 25 of 66 Products

Sort by

Display

Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2013 Product code:171785
Published by	BioSeeker Group AB
Published	April 22, 2013	Content info
Price	US $ 2249

Analytical Tool - Protein Kinase Inhibitors in Oncology Product code:166080
Published by	BioSeeker Group AB
Published	April 22, 2013	Content info
Price	US $ 6674

Small-Molecule Targeted Cancer Therapies: World Market 2013-2023 Product code:226942
Published by	Visiongain
Published	December 10, 2012	Content info	174 Pages
Price	US $ 2497

The Next Wave In Cancer Treatment - Kinase Inhibitors Product code:258246
Published by	Kalorama Information
Published	December 4, 2012	Content info	160 Pages
Price	US $ 2500

Innovative R&D and Dealmaking Opportunities: Oncology - Novel Targeted Small-Molecule Therapies Product code:270336
Published by	Decision Resources, Inc.
Published	November 21, 2012	Content info
Price	US $ 10000

Global Kinase Inhibitors Market 2011-2015 Product code:254951
Published by	Infiniti Research Limited (Technavio)
Published	November 9, 2012	Content info	Pages: 45
Price	US $ 1500

Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets Product code:116974
Published by	BCC Research
Published	October 30, 2012	Content info	138 Pages
Price	US $ 5450

Market and Product Forecasts: Targeted Cancer Therapies 2011-21 - Eurozone price cuts impact targeted cancer therapies market Product code:248080
Published by	Datamonitor
Published	July 20, 2012	Content info	Pages: 88
Price	US $ 11400

Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline Product code:246718
Published by	GBI Research
Published	July 10, 2012	Content info	Pages: 172
Price	US $ 3500

Kinase Inhibitors: Global Markets -- Focus on Asia Product code:246449
Published by	BCC Research
Published	June 30, 2012	Content info	120 pages
Price	US $ 4400

Kinase Inhibitors: Global Markets -- Focus on Europe Product code:246350
Published by	BCC Research
Published	June 30, 2012	Content info	121 Pages
Price	US $ 4400

Kinase Inhibitors: Global Markets -- Focus on the U.S. Product code:246349
Published by	BCC Research
Published	June 30, 2012	Content info	122 Pages
Price	US $ 4400

Kinase Inhibitors: Global Markets -- Focus on Emerging Markets Product code:246348
Published by	BCC Research
Published	June 30, 2012	Content info	119 Pages
Price	US $ 4400

Kinase Inhibitors: Global Markets Product code:104223
Published by	BCC Research
Published	June 26, 2012	Content info	219 pages
Price	US $ 5450

Global Markets for Enzyme Inhibitors -- Focus on the US Product code:245535
Published by	BCC Research
Published	June 22, 2012	Content info	174 Pages
Price	US $ 4400

Global Markets for Enzyme Inhibitors -- Focus on Emerging Markets Product code:245534
Published by	BCC Research
Published	June 22, 2012	Content info	169 Pages
Price	US $ 4400

Global Markets for Enzyme Inhibitors -- Focus on Europe Product code:245533
Published by	BCC Research
Published	June 22, 2012	Content info	174 Pages
Price	US $ 4400

Global Markets for Enzyme Inhibitors Product code:243850
Published by	BCC Research
Published	June 7, 2012	Content info	315 Pages
Price	US $ 5450

Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others Product code:239832
Published by	BioSeeker Group AB
Published	May 1, 2012	Content info	2940 Pages
Price	US $ 4425

G-Protein Coupled Receptors (GPCRs) Product code:240203
Published by	Global Industry Analysts, Inc.
Published	April 1, 2012	Content info	Pages: 299
Price	US $ 4500

Cytokine-Based Therapies and Inhibitors: R&D Pipelines, Markets, and Strategic Issues - Overview Product code:214220
Published by	Insight Pharma Reports
Published	September 20, 2011	Content info
Price	US $ 2495

Kinase-Targeted Therapeutics: Development Pipelines, Challenges, and Opportunities Product code:210216
Published by	Insight Pharma Reports
Published	August 31, 2011	Content info
Price	US $ 3195

Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development Product code:204890
Published by	GBI Research
Published	July 6, 2011	Content info	Pages: 132
Price	US $ 3500

R&D Trends: Rheumatoid Arthritis - Approaching an era of novel kinase inhibitors Product code:206523
Published by	Datamonitor
Published	July 1, 2011	Content info	Pages: 54
Price	US $ 3800

Competitor Analysis: PI3K-AKT-mTOR Inhibitors Product code:203065
Published by	La Merie Publishing
Published	June 27, 2011	Content info	100 Pages
Price	US $ 711

User Guide About Us Policies Site Map

Int'l: +1-860-674-8796 US: +1-866-353-3335 (Toll Free) | EU: +32-2-535-7543 | SG: +65-6223-2436